معرفی
Sarah Kubes, Pharm.D., is a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Sciences at the University of Texas Health Science Center at San Antonio. Her work focuses on quality improvement in pediatric care and infectious diseases, with clinical expertise in pediatrics, infectious disease management, and maternal health. She actively contributes to antibiotic stewardship initiatives and medication adherence research, particularly in cystic fibrosis and pediatric UTI management.
Dr. Kubes’ research emphasizes optimizing antibiotic use in children’s hospitals, evaluating surgical antibiotic prophylaxis, and addressing global antibiotic resistance patterns. Her recent work includes studies on post-COVID pediatric stroke cases and long-term metabolic effects of SSRIs in adolescents. She has collaborated on national and international surveys analyzing pediatric antibiotic prescribing practices and led quality improvement projects like the SHARPS initiative to enhance antimicrobial reporting systems.
Her publications span topics from cystic fibrosis adherence technology to venous thromboembolism risk in pediatric patients with central lines. While no formal awards are listed, her contributions to pediatric pharmacotherapy and antimicrobial stewardship reflect ongoing scholarly impact. No student advising or grant details are provided in the available text.
